T. Rowe Price Investment Management, Inc. Rx Sight, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Rx Sight, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 73,027 shares of RXST stock, worth $2.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,027
Previous 76,033
3.95%
Holding current value
$2.18 Million
Previous $3.76 Million
33.2%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RXST
# of Institutions
222Shares Held
33.4MCall Options Held
531KPut Options Held
50.1K-
Ra Capital Management, L.P. Boston, MA3.74MShares$112 Million2.08% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$71.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$71.1 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.16MShares$64.4 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.55MShares$46.3 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $824M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...